• 17 July 2003

Week on, week off treatment strategy buried at Paris conference

Read the article
  • 18 July 2003

Formula feed is `medicine to prevent HIV`

Read the article
  • 18 July 2003

Kaletra: could upping the dose overcome resistance?

Read the article
  • 18 July 2003

Atazanavir/ritonavir comparable to lopinavir/ritonavir in PI-experienced

Read the article
  • 18 July 2003

US HIV guidelines: choose either lopinavir or efavirenz in first-line treatment

Read the article
  • 20 July 2003

Drug resistant HIV found in 10% of untreated Europeans

Read the article
  • 20 July 2003

Alternating drug regimens may delay HIV treatment failure

Read the article
  • 21 July 2003

Abacavir/3TC/tenofovir study stopped due to high failure rate

Read the article
  • 22 July 2003

No link found between undetectable HIV viral load and unsafe sex in Swiss cohort

Read the article
  • 22 July 2003

Women have larger increase in CD4 cell count after six months of HAART, but no racial differences

Read the article
  • 23 July 2003

Younger HIV patients at increased risk of heart disease

Read the article
  • 24 July 2003

Bacterial STIs more common in HIV-positive gay men since HAART

Read the article
  • 24 July 2003

Amsterdam workshop on scaling up treatment (meeting report)

Read the article
  • 25 July 2003

FTC (Emtriva) recommended for European approval

Read the article
  • 25 July 2003

Instability associated with non-adherence in HAART-treated HIV-positive New Yorkers

Read the article
  • 28 July 2003

Fos-amprenavir (433908) shows signs of weakness in Kaletra comparison

Read the article
  • 28 July 2003

New cases of HIV increase by over 7% in US gay men

Read the article
  • 29 July 2003

Adherence, drug levels and baseline viral load associated with resistance

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.